Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ElixaMD vs FitFlow

ElixaMD
Graded #257

Lower grade

vs+4.099999999999994
FitFlow
Graded #166

Higher grade

The verdict

FitFlow takes it — 67.6/100 to 63.5/100.

FitFlow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FitFlow (FitFlow Health) is a 100% online compounded telehealth platform for GLP-1 weight loss - compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFitFlow +7
50
57
Dose & formulationFitFlow +25
52
77
Clinical oversightElixaMD +7
92
85
Labs & monitoringElixaMD +8
63
55
FulfillmentFitFlow +5
76
81
Contract termsElixaMD +8
45
37
ElixaMD · left barFitFlow · right bar

The numbers

MetricElixaMDFitFlow
WeighScore63.5/10067.6/100
GradeCC
Scorecard rank#257#166
Semaglutide$179/mo (starting dose, first-month rate, compounded)$175/mo (compounded)
TirzepatideNot disclosed$235/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
ElixaMD

Graded #257 · C

Strengths

  • Compounded semaglutide from $179 first month with free shipping, no membership, no contract, and no insurance required
  • Genuinely all-inclusive: 1:1 physician guidance, free dietician visits and care coaching, 24/7 support, and an all-in-one patient portal
  • Names its compounding pharmacies (RedRock Pharmacy, Beaker Pharmacy) — more transparent than most compounded sellers
  • HSA/FSA eligible; full legal suite (Terms, Privacy, Privacy Practices, Refund, Medical Consent, California Bill of Rights)

Where it loses points

  • $179 is a first-month/intro price — ongoing monthly cost is higher (tiers to ~$249-$299)
  • Compounded semaglutide is not FDA-approved (the site discloses this) — not brand Wegovy or Ozempic
  • Appears to offer compounded semaglutide only — tirzepatide is not advertised
  • Displays a generic LegitScript Certified badge but no verifiable seal/listing; state-availability list not published
FitFlow

Graded #166 · C

Strengths

  • Compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro); month-to-month from $175/$235, or as low as $99/$125 on annual prepay
  • 100% online 4-step process; board-certified provider review in 24-48 hours, with unlimited messaging and dose adjustments
  • Free nationwide shipping (discreet, 5-7 days) from US-licensed compounding pharmacies
  • FSA/HSA eligible with financing (Affirm, Klarna, Afterpay); month-to-month or prepay plans, cancel anytime
  • Transparent 'no hidden fees' pricing; 6,000+ members; same-platform add-ons (NAD+, sermorelin, MIC+B12, glutathione, hair, sexual health)

Where it loses points

  • Headline '$99/$125 a month' requires a full year prepaid upfront ($1,188 / $1,500); true month-to-month is $175 / $235
  • Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • The compounding pharmacy partner is not named ('US-licensed / FDA-regulated pharmacies' only)
  • State-availability list is not published (free nationwide shipping advertised, but no explicit state list)
  • No LegitScript certification displayed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard